Evangelos Messaris MD MD, Ph.D, MBA, FACS, FASCRS
Associate Professor of Surgery, Harvard Medical School Division Chief, Colon and Rectal Surgery
Join to View Full Profile
330 Brookline AvenueGryzmish 6Boston, MA 02215
Phone+1 617-667-4159
Fax+1 617-667-2978
Dr. Messaris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Evangelos Messaris, MD, is a Boston-based specialist in Colon and Rectal Surgery. He completed a fellowship in Colon and Rectal Surgery at Penn State Milton S Hershey Medical Center and a surgery residency at Brown University. He serves as Division Chief of Colorectal Surgery at Beth Israel Deaconess Medical Center, Harvard Medical School and is an Associate Professor at Harvard Medical School. Dr. Messaris has expertise in conditions such as inflammatory bowel disease, ulcerative colitis, Crohn's disease, hemorrhoids, and colorectal cancer. He is member of the editorial board of several journals and has published several research articles in reputable journals and has conducted clinical trials. He is board certified from the American Board of Surgery and the American Board of Colon and Rectal Surgery. Furthermore, he is recognized as a Fellow of the American College of Surgeons and the American Society of Colon and Rectal Surgery.
Education & Training
Penn State Milton S Hershey Medical CenterFellowship, Colon and Rectal Surgery, 2010 - 2011
Rhode Island Hospital/Brown University HealthResidency, Surgery, 2005 - 2010
University of AthensClass of 1999
Certifications & Licensure
MA State Medical License 2018 - 2027
PA State Medical License 2010 - 2018
RI State Medical License 2005 - 2010
American Board of Colon and Rectal Surgery Colon & Rectal Surgery
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2015
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2015
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2015
Clinical Trials
- Cimzia Versus Mesalamine for Crohn's Recurrence Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- Trends in survival outcomes for patients younger than 45 years with colon cancer: insights from a 2-decade analysis.Alexander A Xu, Ana Sofia Ore, Patricia Marcolin, Spyridon Papadimatos, Kristen Crowell
Journal of Gastrointestinal Surgery. 2026-05-01 - Complications and Readmissions in Diverting Loop Ileostomies and Loop Colostomies.Kevin R Arndt, Spyridon Papadimatos, Benjamin G Allar, Kiryung Kim, Daniel J Wong
Diseases of the Colon and Rectum. 2026-05-01 - Age-related differences in postoperative outcomes following colectomy for diverticular disease: a National Surgical Quality Improvement Program study.Spyridon Papadimatos, Itzel Elizabeth Vidal Sanchez, Alexander A Xu, Kristen T Crowell, Evangelos Messaris
Journal of Gastrointestinal Surgery. 2026-04-01
Journal Articles
- Prognostic Significance of Tumor Deposits in Stage III Colon CancerEvangelos Messaris, MD, Annals of Surgical Oncology
Press Mentions
Journey to the Summit: Cancer Patient Celebrates Remission with Care TeamMarch 18th, 2025
Beth Israel Deaconess Medical Center’s Rectal Cancer Program Attains National Accreditation from the American College of Surgeons Commission on CancerMarch 12th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
